Researchers and clinicians with Kaiser Permanente Northern California are developing a wide-ranging research agenda to beat COVID-19, working at the accelerated pace demanded by a worldwide pandemic.
As the COVID-19 pandemic began in 2020, DOR researchers committed to investigating all aspects of the new virus and impacts of the pandemic it caused. In DOR’s infectious disease section,…
In the race to find safe and effective treatments for seriously ill patients with COVID-19, Kaiser Permanente Northern California (KPNC) is enrolling patients in nationwide clinical trials and pursuing other innovative treatment options.
Kaiser Permanente researchers have good news for patients, surgeons, anesthesiologists, and hospital administrators who have had to put off elective surgery because of a positive COVID-19 test. Among fully vaccinated patients, there may not be an elevated risk with surgery soon after COVID-19.
Health systems could use data from routine clinical care to identify the onset of upcoming COVID-19 surges as many as 6 weeks before they occur, Kaiser Permanente researchers found in a study published in the journal BMJ Open.
Adults with young children – and exposure to their colds – were less likely to have severe illness from COVID-19 than similar adults without children, a Kaiser Permanente study finds.
Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.
A study following patients with symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in 2022 found 14% of them developed symptoms after having COVID-19.
Division of Research
4480 Hacienda Drive
Pleasanton, CA 94588
Privacy Policy | Terms and Conditions | Your Privacy Choices
Follow us on these external social media sites that will open in a new browser window.
© 2025 Kaiser Permanente Division of Research